The Nebraska Center for Cellular Signaling (NCCS) Live-Cell Imaging Core provides a variety of support mechanisms to investigators within the NCCS and our partnering institutions through consultation services, reagents, and expertise in an array of microscopy techniques. The original goal of making advanced microscopy technologies readily available to the members of the NCCS continues to drive the success of the core and has been extended to support the larger research community. Since its formation at the beginning of Phase II, the Live-Cell Imaging Core has supported investigators through the generation of data for grant submissions and publications. The Live-Cell Imaging Core is composed of facilities with shared live-cell imaging capabilities as well as specialized features for unique applications. As part of Phase III funding of the NCCS, we are requesting funds to support the aims of the Live-Cell Imaging Core.
Aim 1 : Provide and maintain state-of-the-art live-cell microscopy equipment and offer technical support to investigators both within and outside the NCCS.
Aim 2 : Assist in the generation of image acquisition and analysis, allowing investigators to incorporate live-cell microscopy into their thinking and into their projects and increasing the likelihood grant proposals will be funded.
Aim 3 : Expand the capacity for collaboration between our Center and its partnering institutions. During Phase II, the Live-Cell Imaging Core established the technologies and the systems needed for advanced microscopy platforms. Together with strong institutional support, we propose to continue our momentum by implementing super-resolution microscopy capabilities for TIRF (Total Internal Reflection Fluorescence) microscopy and PALM (Photoactivated Localization Microscopy) within the Live-Cell Imaging Core. Addition of these technologies will greatly enhance the ability of NCCS investigators to compete for extramural funding. Long-term sustainability of the Live-Cell Imaging Core will be achieved by: 1) maintaining a strong base of well-funded users;2) expansion of collaborations with users outside the NCCS;and 3) continuation of steady institutional support.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
5P30GM106397-02
Application #
8729609
Study Section
Special Emphasis Panel (ZGM1-TWD-C)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
2
Fiscal Year
2014
Total Cost
$382,952
Indirect Cost
$86,555
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Awasthee, Nikee; Rai, Vipin; Chava, Srinivas et al. (2018) Targeting I?appaB kinases for cancer therapy. Semin Cancer Biol :
Luan, Haitao; Mohapatra, Bhopal; Bielecki, Timothy A et al. (2018) Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Res 78:2524-2535
Xie, Shuwei; Reinecke, James B; Farmer, Trey et al. (2018) Vesicular trafficking plays a role in centriole disengagement and duplication. Mol Biol Cell 29:2622-2631
Kevadiya, Bhavesh D; Woldstad, Christopher; Ottemann, Brendan M et al. (2018) Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics 8:256-276
Qi, Dianjun; Wu, Shaohua; Lin, Haishuang et al. (2018) Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System. ACS Appl Mater Interfaces 10:21825-21835
Tian, Tian; Bi, Chengfeng; Hein, Ashley L et al. (2018) Rac1 is a novel therapeutic target in mantle cell lymphoma. Blood Cancer J 8:17
Huang, Yunlong; Li, Yuju; Zhang, Hainan et al. (2018) Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. Cell Discov 4:19
Fan, Wei; Zhang, Wenting; Alshehri, Sameer et al. (2018) Increasing time on target: utilization of inhibitors of cysteine cathepsins to enhance the tumor retention of receptor-targeted agents. Chem Commun (Camb) 54:11268-11271
Ouellette, Scot P; Messerli, Parker R; Wood, Nicholas A et al. (2018) Characterization of Chlamydial Rho and the Role of Rho-Mediated Transcriptional Polarity during Interferon Gamma-Mediated Tryptophan Limitation. Infect Immun 86:
Nallasamy, Palanisamy; Chava, Srinivas; Verma, Sumit S et al. (2018) PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective. Semin Cancer Biol 52:53-65

Showing the most recent 10 out of 159 publications